Literature DB >> 23216295

The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.

Michele Poletti1, Daniela Frosini, Cristina Pagni, Filippo Baldacci, Martina Giuntini, Sonia Mazzucchi, Gloria Tognoni, Claudio Lucetti, Paolo Del Dotto, Roberto Ceravolo, Ubaldo Bonuccelli.   

Abstract

The side of motor symptom predominance may influence cognitive performance in patients with Parkinson's disease (PD): PD patients with right-side motor symptom predominance typically present difficulties in tasks of language and verbal memory, whereas PD patients with left-side motor symptom predominance typically present difficulties in visuospatial tasks. The current study aimed at investigating the relationship between motor symptom lateralization and cognitive performance in PD patients without the possible confounding effect of dopaminergic drugs, which may enhance or impair cognition on the basis of assessed function and disease stage. From the initial sample of 137 consecutive newly diagnosed drug-naïve (de novo) PD patients, clinical follow-ups and neurological examinations identified 108 right-handed patients with a unilateral motor presentation or a clear motor asymmetry (59 right-PD: 54.6%; 49 left-PD: 45.4%). Any cognitive difference emerged between right-PD patients and left-PD patients at this disease stage. Scores of lateralized motor impairment severity correlated with some cognitive performances: Right motor impairment correlated with a measure of set shifting (Trail Making Test B-A), and left motor impairment correlated with phonemic fluency and tasks with visuospatial material (Colored Progressive Matrices of Raven, Rey-Osterrieth Complex Figure Copy and Immediate Recall). Findings of the current study supported the conclusion that the side of clinical motor predominance scarcely influences cognition in the early untreated stages of PD, suggesting that cognitive differences between subgroups of lateralized PD patients probably may appear in more advanced disease stages.

Entities:  

Mesh:

Year:  2012        PMID: 23216295     DOI: 10.1080/13803395.2012.751966

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  10 in total

1.  Side of motor onset is associated with hemisphere-specific memory decline and lateralized gray matter loss in Parkinson's disease.

Authors:  Eun-Young Lee; Suman Sen; Paul J Eslinger; Daymond Wagner; Lan Kong; Mechelle M Lewis; Guangwei Du; Xuemei Huang
Journal:  Parkinsonism Relat Disord       Date:  2015-02-18       Impact factor: 4.891

2.  Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Authors:  Brenda Hanna-Pladdy; Rajesh Pahwa; Kelly E Lyons
Journal:  J Int Neuropsychol Soc       Date:  2015-04-29       Impact factor: 2.892

3.  Theory of mind performance in Parkinson's disease is associated with motor and cognitive functions, but not with symptom lateralization.

Authors:  Lisa Nobis; Katharina Schindlbeck; Felicitas Ehlen; Hannes Tiedt; Charlotte Rewitzer; Annelien A Duits; Fabian Klostermann
Journal:  J Neural Transm (Vienna)       Date:  2017-06-05       Impact factor: 3.575

4.  Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease.

Authors:  Jay S Schneider; Stephanie Sendek; Chengwu Yang
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

5.  The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease.

Authors:  Jackalina M Van Kampen; David C Baranowski; Harold A Robertson; Christopher A Shaw; Denis G Kay
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

Review 6.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24

7.  Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI.

Authors:  Anneke Alkemade; Gilles de Hollander; Max C Keuken; Andreas Schäfer; Derek V M Ott; Johannes Schwarz; David Weise; Sonja A Kotz; Birte U Forstmann
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

8.  Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Authors:  Edward J Modestino; Chioma Amenechi; AnnaMarie Reinhofer; Patrick O'Toole
Journal:  Brain Behav       Date:  2016-10-19       Impact factor: 2.708

9.  Events Detection of Anticipatory Postural Adjustments through a Wearable Accelerometer Sensor Is Comparable to That Measured by the Force Platform in Subjects with Parkinson's Disease.

Authors:  Tiziana Lencioni; Mario Meloni; Thomas Bowman; Alberto Marzegan; Antonio Caronni; Ilaria Carpinella; Anna Castagna; Valerio Gower; Maurizio Ferrarin; Elisa Pelosin
Journal:  Sensors (Basel)       Date:  2022-03-30       Impact factor: 3.576

10.  Memory for gist and detail information in patients with Parkinson's disease.

Authors:  Rwei-Ling Yu; Chun-Hsiang Tan; Yih-Ru Wu; Ruey-Meei Wu; Ming-Jang Chiu; Mau-Sun Hua
Journal:  BMJ Open       Date:  2015-11-20       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.